West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,900 | 42,100 | 41,600 | 39,300 | 37,800 |
| Receivables | 74,600 | 65,200 | 79,500 | 73,700 | 73,200 |
| Inventories | 36,500 | 34,300 | 42,400 | 41,300 | 43,100 |
| Income taxes - deferred | 2,300 | 2,400 | 8,800 | 8,200 | 7,800 |
| Other current assets | 10,100 | 14,500 | 10,900 | 10,100 | 11,900 |
| TOTAL | $152,400 | $158,500 | $183,200 | $172,600 | $173,800 |
| Non-Current Assets | |||||
| PPE Net | 211,600 | 210,100 | 241,400 | 234,100 | 233,700 |
| Investments And Advances | 19,500 | 20,800 | 20,200 | 20,400 | 21,000 |
| Intangibles | 32,100 | 38,500 | 50,000 | 48,600 | 49,800 |
| Other Non-Current Assets | 91,100 | 83,400 | 81,700 | 79,900 | 78,000 |
| TOTAL | $354,300 | $352,800 | $393,300 | $383,000 | $382,500 |
| Total Assets | $506,700 | $511,300 | $576,500 | $555,600 | $556,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,300 | 4,300 | 500 | 500 | 500 |
| Accounts payable and accrued liabilities | 22,000 | 22,200 | 24,000 | 26,200 | 25,400 |
| Accrued Expenses | 46,700 | 44,400 | 52,200 | 49,600 | 20,300 |
| Other current liabilities | N/A | N/A | N/A | N/A | 27,200 |
| TOTAL | $83,700 | $75,300 | $100,700 | $90,700 | $86,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 171,400 | 184,300 | 195,400 | 195,100 | 195,200 |
| aiOther Non-Current Liabilities | 28,200 | 28,100 | 25,300 | 25,100 | 25,900 |
| TOTAL | $246,400 | $259,200 | $271,700 | $270,900 | $271,800 |
| Total Liabilities | $330,100 | $334,500 | $372,400 | $361,600 | $358,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,690 | 57,678 | 57,382 | 57,346 | 57,335 |
| Common Shares | 4,300 | 4,300 | 4,300 | 4,300 | N/A |
| Retained earnings | 257,300 | 254,000 | 276,300 | 273,200 | N/A |
| Other shareholders' equity | -33,200 | -27,100 | -22,100 | -29,100 | 197,700 |
| TOTAL | $176,600 | $176,800 | $204,100 | $194,000 | $197,700 |
| Total Liabilities And Equity | $506,700 | $511,300 | $576,500 | $555,600 | $556,300 |